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Research Council Clinical and Population Cytogenetics Unit,  Western General Hospital, Edinburgh EH4 
2XU. 
Tumor cells can protect themselves in vitro and in vivo against immune assault by 
such  mechanisms  as  the  secretion  of nonspecific  suppressive  or  anti-inflammatory 
factors (1) or the shedding of tumor-specific antigens (2). In this report we describe a 
further mechanism which can prevent immune effector cells from establishing contact 
with  tumor  cells  in  vitro  and  which,  in  so  doing,  inhibits  lymphocyte-mediated 
cytolysis. 
During attempts to perform cell-mediated cytotoxic assays using adherent fibrosar- 
coma cells as targets, tumor cells were seen to be surrounded by a  large transparent 
halo which spleen cells were unable to penetrate (Figs. 1 a  and 2 a). This report deals 
with the nature of this barrier between tumor and effector cells. It shows how it can 
be  removed  and  how  its removal allows lymphocyte-mediated cytolysis, a  reaction 
inhibited  by  its  presence.  Such  barriers  have  been  demonstrated  on  synovial  and 
fibroblast  cells  (3,  4,  5);  however,  their  presence  on  tumor  cells and  their  role  in 
preventing cell-mediated cytolysis of such cells does not seem to have been previously 
reported. 
Materials  and  Methods 
Cells.  The  tumor  cells most  intensively investigated were  derived from  a  fibrosarcoma, 
induced in C3Hf/Bu mice by methylcholanthrene treatment. Serially  transplanted flank tumors 
in the 7-12th generation were taken and cell suspensions prepared as described previously (6). 
Cells cultured in vitro for up to 15 passages were used in the experiments. A range of other cells 
were also examined:  fibrosarcoma cells W1,  W5,  W9, W14,  Wlll,  Wl12, and  Wl14 were 
kindly provided by Professor M. F. A. Woodruff and Mrs. Gillian Speedy, lymphoblastoid cells 
by Dr. M. Steele, 3T3 cells by Mr. W. Christie, Medical Research Council Cytogenetics Unit; 
mammary carcinoma cells SP22 and 40A by Dr. M. Moore, Christie Hospital and Holt Radium 
Institute, Manchester; VERO and BHK-21 cells by Mr. D. Brown, Bacteriology Department; 
the other tumors used were maintained in our laboratory; fibroblasts from  mouse  14-d-old 
embryos and adult human skin were also used. Additional information on the cells is provided 
4  2  in the text. In all experiments, cell cultures were seeded sparsely at densities of 10  cells cm-  on 
coverslips or in 96 well Microtitre plates No. M29 ART (Sterilin, Teddington, England). Eagle's 
medium (Wellcome, England) supplemented with 10% fetal calf serum (Gibco, Bio-cult, Paisley, 
Scotland) and buffered with 20 mM Hepes (British Drug House Chemicals, Poole, Dorset) was 
used throughout. The formation of halos was dependent on the presence of the serum. 
Cell suspensions were prepared from C3Hf/Bu mouse spleens and washed once before use. 
A T-lymphocyte-enriched population of spleen cells, for use in the microcytotoxicity tests, was 
separated  from  other  spleen  cells  by  nonadherence  to  nylon  wool  (7).  These  suspensions 
contained 80-85% T  cells (8). 
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The optimal ratio of spleen cells to tumor cells for visualising the halos was =3.0  ×  106 
cm -2, i.e., just sufficient to form a cell sheet. 4  X  109 cm  -2 formalin-fixed Corynebacterium parvum 
organisms  were  also  used  to  visualise the  halos  as  was  Pelikan,  shellac-free, drawing  ink 
(Gunther Wagner, Hanover, Germany). It was found that the process of visualisation could be 
hastened by spinning the particles onto the cells using a  conventional centrifuge with plate 
holder or a cytocentrifuge for the slide/coverslip preparations. 
Microscopy.  Whereas  the  halo  phenomenon  could  readily be  seen  using  a  conventional 
inverted microscopy, it could be studied in greater detail if cells were plated on to circular 
coverslips and placed in a Dvorak-Stotler chamber (9; Zeiss, Ober Kochen, W. Germany) or if 
the coverslips were allowed to hang from the underside of a thin slide. Here they were examined 
and  photographed  under  Nomarski optics on  a  Zeiss Universal microscope. For time-lapse 
studies, cells were plated on Falcon plastic dishes with Cooper lids (Becton Dickinson UK, Ltd., 
Middlesex) and filmed on a Wild inverted phase microscope (Wild, Heerbrugg, Switzerland) 
with Wild time-lapse equipment in a 37°C room (10). Lapse rates of 10-100 s were used. 
Enzymes.  Hyaluronidase from bovine testis type 1 (Sigma, Kingston-on-Thames, England) 
and ovine testis (Sigma), both of which also degrade chondroitin sulphate, and hyaluronidase 
ex Streptomyces  (l 1)  grade B  (Calbiochem, San Diego, Calif.) which is specific for hyaluronic 
acid, were used in the study. These enzymes had no detectable activity against the general 
proteolytic substrate azocoll (Calbiochem) and the activity of the fungal hyaluronidase was 
resistant to heating at 60°C for 30 min (11). In other attempts to remove the barriers, cells were 
treated with concentrations of trypsin, pepsin, and pronase (BDH) varying from 0.02 to 0.0002% 
for 20 min at 37°C; 0.002%  DNase I (Sigma), 15 min at 37°C; 0.02%  RNase (Sigma), 15 min 
at  37°C;  and  50  U/ml  Vibrio  cholerae neuraminidase  (BDH),  15  min  at  37°C.  Tests  were 
performed in Eagle's medium containing 10% FCS and in Dulbecco's phosphate-buffered saline 
(PBS); the enzymes were removed by washing and the cells were tested immediately for their 
ability to form halos using spleen cells as indicators. 
Microcytotoxicity  Tests.  104 tumor cells were plated in each well of a 96 well Microtitre plate 
No. M29 ART (Sterilin). After overnight incubation, 10/~Ci Na51CrO4 (Radiochemicals Centre, 
Amersham, Bucks.) were added in 50 #l medium. After 2 h at 37°C, the wells were washed five 
times with warm Dulbecco's PBS and the appropriate number of spleen cells added to each 
well. After a further 7-h incubation period, the supernate was removed, the cells washed once 
in Dulbecco's PBS, and the label associated with the cells was released by treatment with 0.1 
ml 2 N  NaOH. The counts in the experimental wells were subtracted from those in control 
wells to which no spleen cells had been added; this value was then expressed as a percentage of 
the control counts to give the cytotoxic index. When required, cells were treated with 10 IU/ml 
(0.1-ml final volume) bovine testicular or fungal hyaluronidase during the labeling and also 
during the subsequent incubation periods. 
Results 
Our initial observations were made with C3Hf/Bu  fibrosarcoma (Fsa) cells. Typi- 
cally, after culture for longer than 2-4 h, ~80% of these cells prevented normal spleen 
cells from coming close to their cell membranes. The effect was made obvious by the 
presence  of large translucent  halos around  the  tumor  cells which  spleen cells were 
unable  to penetrate  (Figs.  1 a  &  2 a).  No structure was  visible in the halo region by 
either phase contrast, dark ground or Nomarski optics; the halos extended well beyond 
the filopodial attachments seen with high resolution microscopy (Fig.  1 a). 
In one experiment halo sizes were measured;  they ranged up to  17 #m,  averaging 
8.8 #m, from Fsa membrane to spleen cells; the minimum measurable size was 2/~m. 
Halos were formed by cells taken in vitro directly from a tumor or by cells subcuhured 
for up to at least  15 passages in vitro. 
Time-lapse cinemicrography showed that at no time did spleen cells penetrate the 
halos; they were excluded even as they settled on to the surface of the dish, the settling 
pattern suggesting that the halos were not simply associated with the substratum hut W.  H.  McBRIDE  AND J.  B.  L.  BARD  509 
FIG.  1.  Living Fsa cells photographed under Nomarski optics showing the halo phenomenon in 
the presence of (a) spleen cells, 350 × ; (b) fixed C  parvurn organisms,  ×  850; (c) carbon particles, 
×  350. Note that under high magnification (b) the halos extend beyond the fine processes coming 
from the cell body (arrows). Cells were plated 16 h before the indicator particles were added and 
photographed 10 min later. 
extended  above  and  around  the  Fsa cell.  Motile  cells had  very prominent  barriers 
around  their trailing edge  but the halo tended  to  be much  less pronounced at  their 
leading edge  (Fig. 2 a, see legend for details). C
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The exclusion phenomenon was seen with particles other than normal spleen cells. 
Bacteria  (Fig.  1 b)  and  carbon  particles  (Fig.  l c)  showed  halo  formation  as  did 
immune spleen cells, lymph node cells, thymocytes, normal peritoneal exudate cells, 
and erythrocytes. Visualisation of the halos was optimal when the concentration of 
indicator particles was sufficient to form a single layer sheet: at lower concentrations, 
the monolayer was  insufficient to see halos, whereas at high concentrations, spleen 
cells piled up over both the Fsa cells and their halos. It was of interest that fixation of 
the tumor cells in 1% formal saline or 2.5% glutaraldehyde did not remove the barrier; 
after dehydration, however, the halos were no longer visible. 
The C3Hf/Bu Fsa cells were not alone in their ability to exclude particles from the 
region around them. A  variety of normal and tumor cells also were found to possess 
halos (Table 1). A major exception, however, was the seven lymphoblastoid cell lines 
tested.  Vero cells also  appeared  to be negative.  It  should,  however, be noted that 
halos of <2/zm would not be demonstrable. 
These barriers are similar to the hyaluronidase-sensitive material seen to surround 
synovial cells and fibroblasts in vitro (3, 4, 5). We therefore examined the sensitivity 
of the halos formed by the cells detailed in Table 1 to bovine testicular hyaluronidase 
(10 IU/ml).  Treatment with  hyaluronidase removed the barrier so that  the spleen 
cells were then able to approach the cell membranes (Fig. 2); with most cell types, the 
barrier was removed within 3 m, although certain of the carcinoma cells appeared to 
be slightly less sensitive. These concentrations of hyaluronidase appeared to have no 
adverse influence on  the  morphology or growth  of the cells.  After removal of the 
enzyme, the cells regenerated their ability to repel spleen cells within  2 h.  Fungal 
(0.1-10 IU/ml) and ovine testicular (10 IU/ml) hyaluronidase where tested, had the 
same  effect. Other  enzymes  (pronase,  pepsin,  trypsin,  neuraminidase,  collagenase, 
DNase, and RNase) did not remove the barrier when used at concentrations that did 
not obviously affect the morphology and adherence of the cells to glass. 
These results show that  many adherent sarcoma and  carcinoma cells, as well as 
normal cells, are surrounded in vitro by hyaluronidase-sensitive zones that can prevent 
spleen cells as well as other cells and particles approaching their cell membranes. As 
it is thought that contact between effector and target cells is a  prerequisite for cell- 
mediated cytolysis (12), we have investigated the extent to which these halos could 
protect tumor cells from lymphocyte-mediated lysis. 
For these experiments, cells were prepared from the spleens of C3Hf/Bu mice that 
had been bearing Fsa tumors for 14-2 1 d. These spleen cells are known to possess anti 
tumor activity as measured in a  Winn assay (8). The ability of the cells to iyse Fsa 
cells was  measured  in  the presence and  absence of hyaluronidase by a  51Cr-release 
assay. The results of four separate experiments are presented in Table II. Hyaluroni- 
dase did not effect Na51CrO4 uptake by tumor cells; it did not significantly increase 
the 51Cr released by tumor cells cultured with normal spleen cells.  It did, however, in 
all experiments, enhance the SlCr released by Fsa cells in the presence of specifically 
immune  spleen  cells;  the  average  increase  in  lysis  being  around  threefold.  The 
enhanced killing of Fsa cells by immune spleen cells in the presence of hyaluronidase 
was most obvious when nylon wool nonadherent  (T-cell enriched) spleen cell popu- 
lations were used  (exps. 3 b  and 4 b; Table II); the major reason being that T-cell- 
enriched preparations displayed less nonspecific cytotoxicity than did the unseparated 
spleen cells.  The cytotoxic action of immune spleen cells in the presence of hyaluron- 
idase  was  immunologically specific in  that,  in  the  four experiments, we  found no 512  PROTECTIVE  COATS  ON  TUMOR  CELLS 
TABLE  1 
Cell type  Comment  Strain/species  Coat 
Fsa 1 
Fsa W1, W5, W9, W14 
Fsa Wlll,  W112, Wl14 
Mammary carcinoma 2 
Mammary carcinoma SP22 
Mammary carcinoma 40A 
Adenocarcinomas 1, IM, 2 
3T3 G 
3T3 S 
BHK-21 
Mouse embryo fibroblasts 
Adult skin fibroblasts 
MCA*-induced  C3Hf/Bu mice  + ve 
MCA*-induced  CBA mice  all  +ve 
MCA*-induced  Balb/c mice  all  +ve 
Spontaneous  C3Hf/Bu mice  + ve 
Spontaneous  W/not rats  + ve 
AAF:~-indueed  W/not rats  + ve 
Spontaneous  C3Hf/Bu mice  all  + ve 
Fibrobtast-like  Swiss albino mice  + ve 
SV40 transformed  Swiss albino mice  + ve 
Fibroblast-like  Hamster  + ve 
C3Hf/Bu mice  + ve 
Human  + ve 
Vero  Fibroblast-like 
B-lymphocyte lines  EB4,  CRO1,  ANAl, 
G-S1, JIM1 
Myeloma 8226 
T-lymphocyte line MOLT4 
Monkey  -ve 
Human  all -ve 
Human  -ve 
Human  -ve 
* met  hylcholant  hrene-induced 
:]: N  acetyl-a-amino-fluerene-induced 
enhanced cytotoxicity against C3Hf/Bu adenocarcinoma IM cells when the enzyme 
was added (data not shown). These experiments show that the hyaluronidase-sensitive 
zones around tumor cells, in preventing immune lymphocytes from approaching their 
cell membranes, can protect them from specific cell-mediated cytolysis in vitro. 
Discussion 
The results show that, when cultured in vitro, cells from a C3Hf/Bu fibrosarcoma 
are surrounded by zones that particles cannot penetrate and that these zones, which 
are removed by hyaluronidase, can protect the cells from lysis by immune lympho- 
cytes.  A  variety of other sarcoma and  carcinoma  cells as  well  as  normal  cells  had 
similar exclusion zones; the lymphoblastoid cell lines that we tested did not. 
There are only a  few reports in the literature of similar phenomena, a  fact that is 
perhaps surprising.  Halos of a similar thickness have been noted on human synovial 
cells  (3,  4)  and  their  presence  considered  sufficient  to  protect  such  cells  against 
leukocyte-induced damage (5) and to inhibit viral adherence (13).  A similar reaction 
with erythrocytes has been attributed to human polymorphonuclear leukocytes (14) 
but the hyaluronidase-sensitivity of the halo was not investigated in that paper. We 
have been unable to find reports of exclusion zones around tumor cells. We believe 
the  reason  for the  lack of such  reports  is  that  they  are difficult  to  visualise.  They 
appear only 2 h after the cells are in culture and their identification requires indicator 
particles to be present at the correct concentration. 
The  nature  of the  halo  is  largely unknown.  The evidence  that  we have is  most 
compatible with its being a gel-like coat extending beyond the filopodia, encompassing 
the cell mass and being composed in part of hyaluronic acid. Very low concentrations 
of this glycosaminoglycan, perhaps complexed with protein and other polysaccharides 
(15)  could form coats with properties consistent with those we have described as it is 
known  that  hyaluronic  acid  is  heavily hydrated  (16).  Support  for this  view comes W.  H.  McBRIDE AND J.  B.  L.  BARD 
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Effector cells 
Hyalu- 
roni- 
dase* 
Immune~ 
Lysis~ 
125: III  Incr.¶  50:1 
Normal 
Incr.  125:1  Incr.  50:1  Incr. 
Exp. 1 
spleen cells 
Exp. 2 
spleen cells 
Exp. 3 a 
spleen cells 
Exp. 3 b 
T-cell-en- 
riched** 
spleen  cells 
Exp. 4 a 
spleen cells 
--  14  3.5  a  9¶ 
+  49  19 
--  24  1.4`"  12 
+  34  24 
--  10  2.8  a  2¶ 
+  28  28 
-  0¶  >2.7`"  9~ 
+  27  32 
% 
> 1.9"  14  1.3  11  1.5 
17  16 
2.0  16  1.5  21  1.3 
24  28 
>2.8 a  18  <1.0  17  <1.0 
10  10 
>3.2 ~  0  1.0  3  1.0 
5  0 
-  14  3.8`"  29  1.1  51~  1.2  39  1.4 
+  53  33  61  54 
Exp. 4 b 
T-cell-en-  -  13  2.9  ~  0¶  >4.1`"  17  1.0  1  1.0 
dched**  +  38  41  16  9 
spleen  cells 
* 10 IU/ml (0.1-ml vol) bovine testicular (exp. 1, 2, and 4) or fungal (exp. 3) hyaluronidase present. 
::1:1 -  (counts  remaining in wells with added spleen cells + counts remaining in wells with no spleen cells) 
x  100%. This method of calculating precent lysis gave more reproducible results  than  supernatant 
counts although they could equally well have been used. Nonspecific release ~130%. Four replicates  were 
averaged for each percent lysis. 
§ Suspensions  from spleens of mice bearing Fsa for 14-21 d (~i 12 mm diameter tumors). 
II Effector:target cell ratios. 
¶ Lysis in the presence  of hyaluronidase divided by lysis in the absence  of hyaluronidase:  Statistically 
significant increases  (P <  0.05; Student's t test) are shown by a. Where lysis was <10%,  then  10% was 
used for the calculation of the increase. 
** T-cell enriched .- nylon wool nonadherent. 
~:~ Very occasionally high cytotoxicity was found with supposedly  normal spleen cells. The explanation for 
this is presently  unknown. 
from  the  fact  that  dehydration  (though  not  fixation)  removes the halos.  Alternative 
hypotheses,  for example that the barrier is due to fine, active cell processes, require to 
explain the exquisite sensitivity of the halos to the several different types of hyaluron- 
idase and  in particular  to the highly specific, heat stable fungal hyaluronidase. 
The  importance  of these  halos  to  the  cells  is  hard  to  define.  They  may  act  as  a 
protective mechanism  against  the  harsh  conditions  in  vitro, yet  the cells appear  not 
to  be  affected  by  removal  of  the  halos  with  hyaluronidase.  In  the  experimental 
context, we have shown that  halos prevent the approach  of immune  effector lympho- 
cytes to tumor  cells and,  in  so doing,  appear  to protect  the tumor  cells against  lysis. 
The  phenomenon  may  therefore  influence  the  outcome  of certain  microcytotoxicity 
assays.  It  is  known  that  there  are  particular  problems  in  performing  51Cr-release 
microcytotoxicity assays  using adherent  cells as targets;  for such  assays,  lymphoblas- 
told cell lines are most commonly  used  (1 7).  In this regard  it may be significant that 514  PROTECTIVE  COATS ON TUMOR CELLS 
we could not detect halos around any of the lymphoblastoid cell lines tested. 
It is clear that the addition of hyaluronidase may under certain conditions facilitate 
the cytotoxic performance of immune cells against adherent cells in vitro. However, 
other  related  factors  may be  important  in  the  performance of these  assays;  these 
include the extent of halo production and its chemical composition, the time at which 
effector  cells  are  added  with  respect  to  the  time  taken  for  the  establishment  of 
exclusion zones by the targets, and the presence or absence of cells such as activated 
macrophages which may have enzymes capable of breaking down the halo. 
The significance of halo formation by cells in vitro to their behavior in vivo is as yet 
unclear.  It is however of interest  that  hyaluronic acid is a  major component of the 
ground  substance  and  as such  it will  be present  within  solid tumors and would  be 
expected to help maintain the integrity of the tumor. Although it has been suggested 
that  breakdown  of ground  substance  may facilitate spread  of the  tumor  (18),  the 
results presented here suggest that  it would  be worthwhile  investigating whether its 
removal may in fact facilitate penetration and elimination of the tumor by the host's 
immune defences. 
Summary 
A variety of adherent sarcoma, carcinoma and normal cells are surrounded in vitro 
by thick, transparent zones (29 #m thick) that spleen cells and a variety of other cells 
and particles cannot penetrate. Seven lymphoblastoid cell lines did not possess such 
halos. 
The presence of these halos around adherent fibrosarcoma cells appeared to protect 
them from lymphocyte-mediated cytolysis. Hyaluronidase treatment, which destroyed 
the halo and allowed lymphocytes to approach the tumor cell membrane, enhanced 
the cytotoxic action of immune but not of normal spleen cells. 
These observations, in  addition  to highlighting  a  little-known  feature of the cell 
surface, may also be of general relevance to the in vitro and in vivo killing of tumor 
cells by immune effector cells. 
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